Background Current automatic software uses a fixed apparent diffusion coefficient (ADC) threshold (≤620×10⁻⁶ mm²/s) to ...
Alteogen said on the 26th that it completed a Patent Cooperation Treaty (PCT) filing for its technology to develop a subcutaneous injection formulation of antibody-drug conjugate (ADC) medicines. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results